| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_527961230b4afd87dc719a5173777942 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-407 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2020-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c9beb6291864f0bb3b89623038aa567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e82b1cc16bdc31caab7e8e75cdb2af80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fc3f447c6802eeb3111423e4c4f9e3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b74e6eecf9636859fb95f386b14f6d90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1f2eef8771de942bd4539699ec7d0e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d623227c5ca9004d273a3b4cb3532cc |
| publicationDate |
2022-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220004977-A |
| titleOfInvention |
Adult liver progenitor cells to treat acute exacerbations of chronic liver failure |
| abstract |
The present invention provides that treatment comprises administering to the patient said composition in an amount comprising a dose of 0.25x10 6 to 2.5x10 6 progenitor cells/kg body weight; A heterogeneous human adult liver for treating a patient who has developed or is at risk of developing an acute exacerbation of chronic liver failure (ACLF), wherein the composition is substantially free of an effective amount of an anti-aggregant and the patient is not co-treated with an anticoagulant. To the use of a composition comprising human adult liver-derived progenitor cells, such as -derived progenitor cells (HALPC). |
| priorityDate |
2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |